We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Doqit offers a solution for managing life admin tasks, helping you organize important information, set action dates, and receive timely reminders, ultimately streamlining tasks like insurance renewals and warranties to reduce unnecessary expenses and simplify your life. It provides secure storage and easy access for vital information, transitioning from chaos to simplicity.  Security is also a priority for Doqit. The platform ensures that your sensitive information is stored securely, giving you peace of mind knowing that you can access your important documents and data whenever you need them, all within a few clicks.
days to go: Extended investment: £87,500
Morgan Goodwin is a UK-based company that pioneers the Combined Trading Platform (CTP) category, offering a comprehensive online platform for small businesses engaged in physical goods trading, along with specialized software development services, and a broad-spectrum business consultancy approach aimed at enhancing growth, efficiency, and technological advancement.
days to go: Stretch investment: £788,519
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
UTU is a company dedicated to building the trust infrastructure for the evolving web 3.0. They aim to facilitate safer and more reliable interactions between users and platforms by utilizing a decentralized reputation and reviews protocol. This protocol involves a non-tradable reputation token (UTT) that users can stake to endorse others, leading to positive outcomes. UTU's focus initially lies in Web3 and DeFi apps, where they provide AI-powered tools to curate trust signals and help users engage confidently in various online activities. They offer a range of products, including the UTU Trust Token, Browser Extension, and Trust API/SDK, all aimed at enhancing trust and security in digital interactions.
days to go: Extended investment: £150,000
Coinrule is a smart assistant designed for millennials looking to automate their investments in cryptocurrencies, financial assets and build trading strategies without having to program a single line of code. The platform empowers regular traders and investors to compete with professional algorithmic traders and hedge funds. Users can pick 'building blocks' via a simple interface to create trading strategies which also get backtested on historical data. The company aims to make trading an accessible option for all. They have received awards such as MKB Fintech Lab - Cohort 2018, Pioneer 500, and Alpha Startup at Web Summit 2018. Their exit strategy would be a sale to a larger player either in the crypto space (i.e. Binance/Coinbase) or in the traditional brokerage space (i.e. IG Index, Fidelity).

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £160,000
Debtech is a legal intelligence platform that aims to become a global automation portal for every type of finance agreement - from simple mortgages to billion-dollar corporate loans. Debtech has a two-tiered format for its business. Its Tier 1 'Platform' connects finance stakeholders - from lenders and lawyers to CFOs and borrowers - on one single platform so that everyone is in one place for the lifecycle of the agreement. Its Tier 2 'Marketplace' is an 'App Store' of simple, plug-and-play apps where one app automates one manual workflow. The company asserts that the global legal intelligence market would touch £29.5 billion by value in 2026. Debtech cites that its portal allows finance organisations to achieve time savings of over 90% and cost savings of up to 50x compared to conventional offline platforms. The company seeks to raise £150,000 (SEIS) of equity funding to upgrade the platform's infrastructure for Most Valuable Product (MVP) Version 1 within 90-days to create MVP V2, onboard its six early corporate customers for paid trials on MVP v2, and build five core apps.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £159,512
Seers Group LTD is a Data protection and Cybersecurity leader in the UK. It's a one-stop-shop for all industries related to the new data privacy laws and cybersecurity. In fact, it considers itself the UK's number one GDPR and cybersecurity expert. Seers Group is partnering with several businesses, accountancy firms, membership bodies, and has access to 300k businesses, which include even the early stage business. Furthermore, its user base is growing by 300% MoM. Seers' aim is to build a Business Development and Support staff to end partnership deals and give expert advice wherever needed.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £255,001
EMERGEiQ is a cloud-based platform targeted towards Small and Medium Enterprises (SMEs) and large corporate organisations. The company plans on having an extensive suite of algorithms that simplifies Data Science (DS) and Artificial Intelligence (AI) at low cost, across all sectors. EMERGEiQ asserts that its analytics can help businesses improve operational productivity, cut costs, and eventually generate more revenue. It has worked with companies across a variety of sectors such as finance, medicine, stock market, and insurance. The company will use will 30% of the investment for R&D, 25% to purchase software and hardware to improve platform capabilities, 25% to market its new product line, 10% as working capital, and 10% as miscellaneous expenses.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £150,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph